C
Clarissa Moreira
Researcher at Burnet Institute
Publications - 18
Citations - 461
Clarissa Moreira is an academic researcher from Burnet Institute. The author has contributed to research in topics: Artemether/lumefantrine & Artesunate/amodiaquine. The author has an hindex of 7, co-authored 16 publications receiving 346 citations. Previous affiliations of Clarissa Moreira include University of Oxford & Kenya Medical Research Institute.
Papers
More filters
Journal ArticleDOI
The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
Jane Achan,Ishag Adam,Emmanuel Arinaitwe,Elizabeth A. Ashley,Ghulam Rahim Awab,Ghulam Rahim Awab,Mamadou S. Ba,Karen I. Barnes,Quique Bassat,Steffen Borrmann,Steffen Borrmann,Teun Bousema,Teun Bousema,Prabin Dahal,Umberto D'Alessandro,Umberto D'Alessandro,Timothy M. E. Davis,Arjen M. Dondorp,Grant Dorsey,Chris Drakeley,Caterina I. Fanello,Babacar Faye,Jennifer A. Flegg,Oumar Gaye,Peter W. Gething,Raquel González,Philippe J Guerin,Simon I. Hay,Tran Tinh Hien,Tran Tinh Hien,Bart Janssens,Moses R. Kamya,Corine Karema,Harin Karunajeewa,Moussa Koné,Bertrand Lell,Kevin Marsh,Kevin Marsh,Mayfong Mayxay,Mayfong Mayxay,Clara Menéndez,Petra F. Mens,Martin M Meremikwu,Clarissa Moreira,Clarissa Moreira,Ivo Mueller,Ivo Mueller,Carolyn Nabasumba,Michael Nambozi,Jean Louis Ndiaye,Paul N. Newton,Paul N. Newton,Thuy Nguyen,François Nosten,François Nosten,Christian Nsanzabana,Sabah A. Omar,Jean-Bosco Ouédraogo,Louis K. Penali,Mbaye Pene,Aung Pyae Phyo,Patrice Piola,Ric N. Price,Ric N. Price,P. Sasithon,Philip J. Rosenthal,Albert Same-Ekobo,Patrick Sawa,Henk D. F. H. Schallig,Seif Shekalaghe,Carol Hopkins Sibley,Jeff Smith,Frank Smithuis,Anyirékun Fabrice Somé,Kasia Stepniewska,Ambrose O. Talisuna,Joel Tarning,Joel Tarning,Emiliana Tjitra,Roger Tine,Halidou Tinto,Neena Valecha,Michel Van Herp,Michèle van Vugt,Nicholas J. White,Nicholas J. White,Charles J. Woodrow,William Yavo,Adoke Yeka,Issaka Zongo +89 more
TL;DR: In this paper, the influence of different dosing schedules on Dihydroartemisinin-piperaquine (DP) clinical efficacy was investigated, and a multivariable model was used to identify risk factors for parasite recrudescence.
Journal ArticleDOI
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
Nicholas M. Anstey,Ric N. Price,Tme Davis,Harin Karunajeewa,Ivo Mueller,Umberto D'Alessandro,Achille Massougbodji,Frederic Nikiema,Jean-Bosco Ouédraogo,Halidou Tinto,Issaka Zongo,Albert Same-Ekobo,M Kone,H Menan,AO Toure,William Yavo,Poul-Erik Kofoed,Bereket Alemayehu,Daddi Jima,Elisabeth Baudin,Emmanuelle Espie,Carolyn Nabasumba,Loretxu Pinoges,Birgit Schramm,Michel Cot,Philippe Deloron,Jean-François Faucher,Jean-Paul Guthmann,Bertrand Lell,Steffen Borrmann,George O. Adjei,J Ursing,Emiliana Tjitra,Kevin Marsh,Judy Peshu,Elizabeth Juma,Bernhards Ogutu,Sabah A. Omar,Patrick Sawa,Ambrose O. Talisuna,Maniphone Khanthavong,M Mayxay,Paul N. Newton,Patrice Piola,Abdoulaye Djimde,Ogobara K. Doumbo,Bakary Fofana,Issaka Sagara,Quique Bassat,Raquel González,Clara Menéndez,Frank Smithuis,Teun Bousema,Piet A. Kager,P. F. Mens,Hdfh Schallig,I Van den Broek,M. van Vugt,Maman Laminou Ibrahim,Catherine O. Falade,Martin M Meremikwu,José Pedro Gil,Corine Karema,Ba,Babacar Faye,Oumar Faye,Gaye O,Jean Louis Ndiaye,Mbaye Pene,Doudou Sow,K Sylla,Rck Tine,Louis K. Penali,Karen I. Barnes,Lesley Workman,Angeles Lima,Ishag Adam,Nahla B Gadalla,Efm Malik,Anders Björkman,Andreas Mårtensson,Billy Ngasala,Lars Rombo,P Aliu,Stephan Duparc,Scott G. Filler,Blaise Genton,Eva Maria Hodel,Piero Olliaro,S Abdulla,Erasmus Kamugisha,Zulfiqarali Premji,Seif Shekalaghe,Elizabeth A. Ashley,Verena I. Carrara,Rose McGready,François Nosten,Abul Faiz,Sue J. Lee,Nicholas J. White,Arjen M. Dondorp,Jeff Smith,Joel Tarning,Jane Achan,Hasifa Bukirwa,Adoke Yeka,Emmanuel Arinaitwe,Sarah G. Staedke,Kamya,Fred Kironde,Chris Drakeley,Mary C. Oguike,Colin J. Sutherland,Francesco Checchi,Prabin Dahal,Jennifer A. Flegg,Philippe J Guerin,Clarissa Moreira,Christian Nsanzabana,Carol Hopkins Sibley,Kasia Stepniewska,Peter W. Gething,Si Hay,Brian Greenwood,Stephen A. Ward,P. A. Winstanley,Grant Dorsey,Bryan Greenhouse,P. Rosenthal,Anastasia Grivoyannis,Kamal Hamed,J Hwang,PS Kachur,Michael Nambozi +133 more
TL;DR: The recommended dose of artemether-lumefantrine provides reliable efficacy in most patients with uncomplicated malaria, however, therapeutic efficacy was lowest in young children from Asia and young underweight children from Africa; a higher dose regimen should be assessed in these groups.
Journal ArticleDOI
A systematic review of sub-microscopic Plasmodium vivax infection.
TL;DR: Quantifying P.vivax parasitaemia by PCR rather than microscopy consistently increased prevalence estimates by a factor of 2.3, suggesting molecular methods have potential to be scaled up to improve the detection of P. vivax transmission reservoirs.
Journal ArticleDOI
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis
Salim Abdulla,Elizabeth A. Ashley,Quique Bassat,Delia Bethell,Anders Björkman,Steffen Borrmann,Umberto D'Alessandro,Prabin Dahal,Nicholas P. J. Day,Mahamadou Diakite,Abdoulaye Djimde,Arjen M. Dondorp,Socheat Duong,Michael D. Edstein,Rick M. Fairhurst,M. Abul Faiz,Catherine O. Falade,Jennifer A. Flegg,Carole Fogg,Raquel González,Brian Greenwood,Philippe J Guerin,Jean-Paul Guthmann,Kamal Hamed,Tran Tinh Hien,Ye Htut,Elizabeth Juma,Pharath Lim,Andreas Mårtensson,Mayfong Mayxay,Olugbenga A. Mokuolu,Clarissa Moreira,Paul N. Newton,Harald Noedl,François Nosten,Bernhards Ogutu,Marie A. Onyamboko,Seth Owusu-Agyei,Aung Pyae Phyo,Zul Premji,Ric N. Price,Sasithon Pukrittayakamee,Michael Ramharter,Issaka Sagara,Youry Se,Seila Suon,Kasia Stepniewska,Stephen A. Ward,Nicholas J. White,P. A. Winstanley +49 more
TL;DR: In western Cambodia, the region with the highest prevalence of artemisinin resistance, there was no evidence for increasing PC1/2 since 2007 and the relationships between parasite clearance and risk of recrudescence during follow-up were assessed.
Journal ArticleDOI
Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS).
Denton Callander,Clarissa Moreira,Carol El-Hayek,Carol El-Hayek,Jason Asselin,Caroline van Gemert,Caroline van Gemert,Lucy Watchirs Smith,Long Nguyen,Wayne Dimech,Douglas Boyle,Basil Donovan,Basil Donovan,Mark Stoove,Mark Stoove,Margaret Hellard,Margaret Hellard,Rebecca Guy +17 more
TL;DR: ACESS is a unique system with the ability to track efforts to control STIs and BBVs—including through the calculation of powerful epidemiological indicators—by identifying response gaps and facilitating the evaluation of programs and interventions.